A Toronto-based healthcare company announced the closing of its bought deal short form prospectus offering pursuant to which the Company issued 46,000,000 units of the Company at a price of $0.30 per Unit for gross proceeds to the Company of $13,800,000. Mackie Research Capital Corporation acted as sole underwriter and bookrunner for the Auxly Cannabis Group Inc. (OTCQX:CBWTF) (TSX-V:XLY) offering.
Auxly Cannabis Group Inc. is a consumer-packaged goods company in the cannabis products market. Its focus is on developing, manufacturing and distributing branded cannabis products.
Traders seemed to be excited on the announcement as shares traded over the counter up to $0.2251/share (+4.7%) following the news. This move was a breath of fresh air for those shareholders that have been holding over the last month as there has been a slight decline in momentum in the preceding three-month rally.
